Edit

Tobacco Regulation Report

The latest national tobacco rules and news—and what may be on the horizon
Tobacco Regulation Report

TPSAC: The Latest—Reynolds Snus Products

In the latest development surrounding the FDA and the tobacco category, the agency issued what it calls a Federal Register notice announcing its TPSAC review six of Reynolds’ snus products from ...

Tobacco Regulation Report

TPSAC: What Happens at Review Meetings?

Before a meeting, TPSAC members receive materials prepared by the FDA and the manufacturer—in this case, Reynolds—that provide context to inform TPSAC members’ discussion, including ...

In April 2015, TPSAC members voted against the MRTP application from Swedish Match North America regarding its General Snus products. Officials with the Richmond, Va.-based tobacco manufacturer said t...

Generally, the role of TPSAC is to review and evaluate scientific issues, including safety, dependence and health issues relating to tobacco products, and provide advice, information and recommendatio...

Public comments have an important role in the MRTP review process, the agency said, and the FDA recognizes that TPSAC meetings provide the public with an opportunity to present information to TPSAC me...

The ANPRM on product standards for flavored tobacco products seeks comments, data, research results or other information on:—The role flavors may play in initiation and tobacco use, especia...

The FDA also extended the deadline for manufacturers and retailers to comply with new warning statements required for packaging and advertisements on cigarette tobacco, roll-your-own tobacco, pipe tob...

The new warning statements also apply to advertisements, including those created by retailers. The kinds of retailer-created advertisements that fall under the statute include promotional materials (p...

On April 24, 2018, the FDA’s Center for Tobacco Products (CTP) sent a letter to San Francisco-based Juul Labs, addressing the recent media attention surrounding youth usage of the popular vaping...

An advance notice of proposed rulemaking (ANPRM) is the third step in the nine-step process required of the FDA in drafting and adopting regulations and new standards. During this step, the agency can...

  • Page 4